Highbridge Capital Management’s Verona Pharma VRNA Stock Holding History

Highbridge Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500,000	Closed	-$53.4M	–	318
2025 Q3	$53.4M	Buy	+500,000	New	+$52.2M	2.32%	8

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Highbridge Capital Management's VRNA Position: Q4 2025 in Review

Highbridge Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 500,000 shares — an estimated $53.4M sold.

Highbridge Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $53.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Highbridge Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Highbridge Capital Management sold 500,000 Verona Pharma shares in Q4 2025, an estimated $53.4M.
Highbridge Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Highbridge Capital Management's Verona Pharma position peaked at $53.4M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Highbridge Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.